Syncom Formulations (India) consolidated net profit rises 49.41% in the September 2025 quarter
Sales rise 18.97% to Rs 121.72 crore
Net profit of Syncom Formulations (India) rose 49.41% to Rs 16.60 crore in the quarter ended September 2025 as against Rs 11.11 crore during the previous quarter ended September 2024. Sales rose 18.97% to Rs 121.72 crore in the quarter ended September 2025 as against Rs 102.31 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales121.72102.31 19 OPM %15.1211.89 -PBDT23.3916.15 45 PBT22.0414.85 48 NP16.6011.11 49Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 13 2025 | 7:48 AM IST